Iradimed Reports Q3 Revenue Record, Issues Q4 & 2026 Guidance
Iradimed Corp reported third quarter revenue of $24.2 million, up 18% sequentially, and announced a quarterly dividend of $0.20 per share. The company lifted its full-year revenue guidance and reaffirmed its position to penetrate the MRI monitoring market.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed